Takeda Pharmaceutical Co Ltd ADR Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 30 trades in Takeda Pharmaceutical Co Ltd ADR (NYSE: TAK) since 2017, across 7 members, worth an estimated $411.51K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 19 buys against 11 sells, a modestly buy-led skew, with Democratic members responsible for 23% of the trades and Republican members 77%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Takeda Pharmaceutical Co Ltd ADR's current Quantellect Tide Score is 38 out of 100 (Calm Tide), Bottom 28% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Takeda Pharmaceutical Co Ltd ADR (TAK) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Takeda Pharmaceutical Co Ltd ADR congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Mar 9, 2026 | Feb 13, 2026 | 24 days | SELL |  $1,001 - $15,000 | +1.05% | Spouse |
Takeda Pharmaceutical Co Ltd ADR (TAK) congressional trading FAQ
Can members of Congress legally trade Takeda Pharmaceutical Co Ltd ADR (TAK) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Takeda Pharmaceutical Co Ltd ADR (TAK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Takeda Pharmaceutical Co Ltd ADR (TAK) trades public?
Yes. Every congressional trade in Takeda Pharmaceutical Co Ltd ADR (TAK) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Takeda Pharmaceutical Co Ltd ADR (TAK)?
Members of Congress have disclosed 30 trades in Takeda Pharmaceutical Co Ltd ADR (TAK) worth $411.51K across 7 members, according to public STOCK Act filings.
Which members of Congress have traded Takeda Pharmaceutical Co Ltd ADR (TAK)?
Recent and active filers of Takeda Pharmaceutical Co Ltd ADR (TAK) disclosures include Rohit Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Takeda Pharmaceutical Co Ltd ADR (TAK) more?
Across disclosed Takeda Pharmaceutical Co Ltd ADR (TAK) trades, 23% were by Democrats and 77% by Republicans, led by Republicans (77%).
What is the most recent congressional Takeda Pharmaceutical Co Ltd ADR (TAK) trade?
The most recent disclosed Takeda Pharmaceutical Co Ltd ADR (TAK) trade was a sale by Rohit Khanna, filed Mar 8, 2026.
What is Takeda Pharmaceutical Co Ltd ADR (TAK)'s Tide Score?
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Quantellect Tide Score of 38 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewTakeda Pharmaceutical Co Ltd ADR (TAK) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.